The FDA's Alzheimer's betrayal
On June 7, the Food and Drug Administration (FDA) approved a new drug from Biogen - Aduhelm - for the treatment of Alzheimer's Disease after a gap of approximately 20 years since t…
On June 7, the Food and Drug Administration (FDA) approved a new drug from Biogen - Aduhelm - for the treatment of Alzheimer's Disease after a gap of approximately 20 years since t…